Abiopharma

The company’s liability position as of 31.3.26, by maturity dates

Quarterly report 1 for the year 2026

Dividend in the amount of 130.5646 agorot per share, ex-dividend date 4.6.26, payment 22.6.26

Events and transactions

Change in holdings of interested parties/officers - Linda Ben Shoshan

Register of shareholders, changes and capital status – changes in the company’s capital as a result of expiration and exercise of warrants

The company’s obligations position as of 31.3.26, by maturity dates

Quarterly report 1 for the year 2026

PRIMERICA HOUSEHOLD BUDGET INDEX™ (HBI™): Rising Gas Prices Limit Purchasing Power of Middle-Income Americans in April

Sidus Space Announces Pricing of $100 Million Registered Direct Offering of Class A Common Stock